Role of tumor necrosis factor‐α and platelet‐activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
1988 • 19,632 citations
Angiogenic Factors
1987 • 3,702 citations
Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
1992 • 2,130 citations
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
1992 • 1,612 citations
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
1987 • 1,210 citations
INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS
1989 • 1,137 citations
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993 • 1,031 citations
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
1990 • 963 citations
Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis
1995 • 917 citations
A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
1992 • 807 citations
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
1987 • 718 citations
Quantitative analysis of cytokine gene expression in rheumatoid arthritis.
1990 • 610 citations
Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis
1991 • 585 citations
Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
1988 • 570 citations
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
1994 • 570 citations
Peptide Regulatory Factors
1989 • 498 citations
Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
1987 • 364 citations
Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
1988 • 335 citations
Tumour necrosis factor in synovial exudates.
1988 • 242 citations
Synovial fluid concentration of five different cytokines in rheumatic diseases.
1990 • 226 citations
Analysis of the histologic variation of synovitis in rheumatoid arthritis
1988 • 217 citations
Localization of tumor necrosis factor receptors in the synovial tissue and cartilage‐pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor α
1992 • 216 citations
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.
1992 • 212 citations
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
1988 • 191 citations
Role of the SIKVAV Site of Laminin in Promotion of Angiogenesis and Tumor Growth: An In Vivo Matrigel Model
1992 • 185 citations
Production of platelet-activating factor by chick retina.
1986 • 157 citations
Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
1995 • 156 citations
Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
1987 • 152 citations
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.
1994 • 149 citations
Stimulation of neovascularization by human rheumatoid synovial tissue macrophages
1986 • 137 citations
Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
1989 • 117 citations
Characteristics of tumor necrosis factor production in rheumatoid arthritis
1989 • 115 citations
Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
1990 • 114 citations
Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.
1995 • 108 citations
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
1995 • 102 citations
Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints
1992 • 93 citations
PAF molecular heterogeneity: pathobiological implications.
1993 • 78 citations
Role of α1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients
1992 • 29 citations
Cited By (0)
No citing papers found in database